The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

(2017) Kjell Oberg et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours

(2017) Stefano Partelli et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents

(2017) Marianne Pavel et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

(2017) Anders Sundin et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

(2017) Aurel Perren et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

(2017) Gregory Kaltsas et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

(2017) Rodney J. Hicks et al.   NEUROENDOCRINOLOGY

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

(2017) Jonathan Strosberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas

(2016) Laura H. Tang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

(2016) James C Yao et al.   LANCET

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

(2016) M. Falconi et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

(2016) M. Pavel et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

(2016) R. Garcia-Carbonero et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum

(2016) B. Niederle et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)

(2016) U.-F. Pape et al.   NEUROENDOCRINOLOGY

Remission of Follicular Lymphoma after Treatment for Hepatitis C Virus Infection

(2016) Nicola Maciocia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case–Control Study

(2015) Eran Sadot et al.   ANNALS OF SURGICAL ONCOLOGY

Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours

(2014) Raghava Kashyap et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature

(2014) Camilla Bardram Johnbeck et al.   Future Oncology

The Efficacy of Hepatic 90Y Resin Radioembolization for Metastatic Neuroendocrine Tumors: A Meta-Analysis

(2014) Z. Devcic et al.   JOURNAL OF NUCLEAR MEDICINE

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis

(2013) Jigang Yang et al.   ACTA RADIOLOGICA

The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods

(2013) Amir Qaseem   ANNALS OF INTERNAL MEDICINE

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

(2013) M. Ducreux et al.   EUROPEAN JOURNAL OF CANCER

Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis

(2013) Håkan Geijer et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Observational Study of Natural History of Small Sporadic Nonfunctioning Pancreatic Neuroendocrine Tumors

(2013) Sébastien Gaujoux et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification

(2013) I. Velikyan et al.   JOURNAL OF NUCLEAR MEDICINE

The Genetics of Neuroendocrine Tumors

(2013) Kjell Öberg   SEMINARS IN ONCOLOGY

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

(2012) H. Sorbye et al.   ANNALS OF ONCOLOGY

Value of Surgery in Patients With Negative Imaging and Sporadic Zollinger-Ellison Syndrome

(2012) Jeffrey A. Norton et al.   ANNALS OF SURGERY

Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases (Br J Surg2012; 99: 1480-1486)

(2012) A. Frilling   BRITISH JOURNAL OF SURGERY

TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study

(2012) G. Rindi et al.   JNCI-Journal of the National Cancer Institute

Hepatic Arterial Embolization versus Chemoembolization in the Treatment of Liver Metastases from Well-Differentiated Midgut Endocrine Tumors: A Prospective Randomized Study

(2012) Frédérique Maire et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

(2012) Marianne Pavel et al.   NEUROENDOCRINOLOGY

Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors

(2011) Deepti Dhall et al.   HUMAN PATHOLOGY

68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors

(2011) T. D. Poeppel et al.   JOURNAL OF NUCLEAR MEDICINE

Carcinoid tumors of the appendix: A population-based study

(2011) John T. Mullen et al.   JOURNAL OF SURGICAL ONCOLOGY

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

(2011) Marianne E Pavel et al.   LANCET

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

(2011) Eric Raymond et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors

(2010) T. Binderup et al.   CLINICAL CANCER RESEARCH

68Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours

(2010) Valentina Ambrosini et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET

(2010) T. Binderup et al.   JOURNAL OF NUCLEAR MEDICINE

The Pathologic Classification of Neuroendocrine Tumors

(2010) David S. Klimstra et al.   PANCREAS

Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon α for advanced carcinoid tumors: FNCLCC–FFCD 9710

(2009) Laetitia Dahan et al.   ENDOCRINE-RELATED CANCER

Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors

(2009) Jonathan Strosberg et al.   HUMAN PATHOLOGY

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

(2009) Anja Rinke et al.   JOURNAL OF CLINICAL ONCOLOGY

Bone Metastases in Patients with Neuroendocrine Tumor: 68Ga-DOTA-Tyr3-Octreotide PET in Comparison to CT and Bone Scintigraphy

(2009) D. Putzer et al.   JOURNAL OF NUCLEAR MEDICINE

Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors

(2008) Ulrich‐Frank Pape et al.   CANCER

Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism

(2008) D. Vezzosi et al.   CLINICAL ENDOCRINOLOGY

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY